Stocks
Kelleher Financial Advisors Boosts Stake in Biotech Giant Amgen Inc.
Kelleher Financial Advisors has increased its stake in biotechnology company Amgen Inc. by 96.4% over the second quarter, according to its latest Form 13F filing with the SEC.
The firm now owns a total of 5,256 shares of Amgen's stock, valued at $1,903,000, after purchasing an additional 2,580 shares during the period.
This is not an isolated instance, as several other hedge funds and institutional investors have also increased their stakes in Amgen over the past quarter.